TY - JOUR
T1 - Early-Onset Parkinsonism and Early-Onset Parkinson's Disease
T2 - A Population-Based Study (2010-2015)
AU - Camerucci, Emanuele
AU - Stang, Cole D.
AU - Hajeb, Mania
AU - Turcano, Pierpaolo
AU - Mullan, Aidan F.
AU - Martin, Peter
AU - Ross, Owen A.
AU - Bower, James H.
AU - Mielke, Michelle M.
AU - Savica, Rodolfo
N1 - Funding Information:
The authors thank Lea Dacy, Mayo Clinic Department of Neurology, for proofreading and formatting of this article. This study was partially funded by Aca- Messrs. Stang, Mullan, and Martin and Drs. Camerucci, Hajeb, and Turcano report no disclosures. Dr. Mielke receives funding from the National Institutes of Health, and unrestricted research grants from Biogen and Lundbeck; she has consulted for Lysosomal Therapeutics, Inc, and Eli Lilly. Dr. Ross receives support from the National Institute of Neurological Disorders and Stroke, the U.S. Department of Defense, and the Michael J. Fox Foundation for Parkinson’s Research. Dr. Bower receives support from the Parkinson’s Disease Foundation. Dr. Savica receives support from the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the Parkinson’s Disease Foundation, and Acadia Pharmaceuticals. Dr. Savica received unrestricted research grant support from Acadia Pharmaceuticals, Inc. during the research and preparation of this manuscript.
Publisher Copyright:
© 2021 - IOS Press. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Background: Early-onset Parkinson's disease (EOPD), occurring between ages 40 and 55, carries social, societal, and personal consequences and may progress, with fewer comorbidities than typical, later-onset disease. Objective: To examine the incidence and survival of EOPD and other Parkinsonism occurring before age 55 in the population-based cohort of residents in seven Minnesota counties. Methods: A movement-disorder specialist reviewed all the medical records in a 2010-2015 Parkinsonism-incident cohort to confirm diagnosis and subtypes. Results: We identified 27 patients diagnosed at ≤ 50 years with incident Parkinsonism 2010-15:11 (41%) cases of EOPD, 13 (48%) drug-induced Parkinsonism, and 3 (11%) other Parkinsonism; we also identified 69 incident cases of Parkinsonism ≤ 55 years, of which 28 (41%) were EOPD, 28 (41%) DIP, and 13 (19%) other Parkinsonism. Overall incidence for Parkinsonism ≤ 50 years was 1.98/100,000 person-years, and for EOPD was 0.81/100,000 person-years. In patients ≤ 55 years, Parkinsonism incidence was 5.05/100,000 person-years: in EOPD, 2.05/100,000 person-years. Levodopa-induced dyskinesia was present in 45%of EOPD (both ≤ 50 years and ≤ 55 years). Onset of cardinal motor symptoms was proximate to the diagnosis of EOPD, except for impaired postural reflexes, which occurred later in the course of EOPD. Among the 69 Parkinsonism cases ≤ 55 years, 9 (13%; all male) were deceased (only 1 case of EOPD). Men had a higher mortality risk compared to women (p = 0.049). Conclusion: The incidence of EOPD ≤ 50 years was 0.81/100,000 person-years (1.98 in Parkinsonism all type); prior to ≤ 55 years was 2.05/100,000 person-years (5.05 in Parkinsonism all type) with higher incidence in men than women. Men with Parkinsonism, all type, had higher mortality compared to women.
AB - Background: Early-onset Parkinson's disease (EOPD), occurring between ages 40 and 55, carries social, societal, and personal consequences and may progress, with fewer comorbidities than typical, later-onset disease. Objective: To examine the incidence and survival of EOPD and other Parkinsonism occurring before age 55 in the population-based cohort of residents in seven Minnesota counties. Methods: A movement-disorder specialist reviewed all the medical records in a 2010-2015 Parkinsonism-incident cohort to confirm diagnosis and subtypes. Results: We identified 27 patients diagnosed at ≤ 50 years with incident Parkinsonism 2010-15:11 (41%) cases of EOPD, 13 (48%) drug-induced Parkinsonism, and 3 (11%) other Parkinsonism; we also identified 69 incident cases of Parkinsonism ≤ 55 years, of which 28 (41%) were EOPD, 28 (41%) DIP, and 13 (19%) other Parkinsonism. Overall incidence for Parkinsonism ≤ 50 years was 1.98/100,000 person-years, and for EOPD was 0.81/100,000 person-years. In patients ≤ 55 years, Parkinsonism incidence was 5.05/100,000 person-years: in EOPD, 2.05/100,000 person-years. Levodopa-induced dyskinesia was present in 45%of EOPD (both ≤ 50 years and ≤ 55 years). Onset of cardinal motor symptoms was proximate to the diagnosis of EOPD, except for impaired postural reflexes, which occurred later in the course of EOPD. Among the 69 Parkinsonism cases ≤ 55 years, 9 (13%; all male) were deceased (only 1 case of EOPD). Men had a higher mortality risk compared to women (p = 0.049). Conclusion: The incidence of EOPD ≤ 50 years was 0.81/100,000 person-years (1.98 in Parkinsonism all type); prior to ≤ 55 years was 2.05/100,000 person-years (5.05 in Parkinsonism all type) with higher incidence in men than women. Men with Parkinsonism, all type, had higher mortality compared to women.
KW - Early-onset Parkinson's disease (EOPD)
KW - incident cohort
KW - prevalence
KW - rochester epidemiology project (REP)
UR - http://www.scopus.com/inward/record.url?scp=85112185714&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112185714&partnerID=8YFLogxK
U2 - 10.3233/JPD-202464
DO - 10.3233/JPD-202464
M3 - Review article
C2 - 33720851
AN - SCOPUS:85112185714
SN - 1877-7171
VL - 11
SP - 1197
EP - 1207
JO - Journal of Parkinson's Disease
JF - Journal of Parkinson's Disease
IS - 3
ER -